No Correlation Between SF3B1 Mutation in Myelodysplastic Syndrome and Overall Survival
Researchers evaluated 15 studies in patients with myelodysplastic syndrome to determine the prognostic value of mutations in the SF3B1 gene.
Researchers evaluated 15 studies in patients with myelodysplastic syndrome to determine the prognostic value of mutations in the SF3B1 gene.
The presence of rheumatologic conditions was also associated with variations in cancer site for both diffuse large B-cell lymphoma and marginal zone lymphoma.
Researchers argue that palliative care integration into treatment regimens contribute to improving the quality of life for patients in phase 1 clinical trials.
Variability in minimal residual disease measurement techniques inhibits the ability to compare data across laboratories and clinical trials.
A retrospective study of platelet- and infection-related data from patients with ITP revealed the influence platelet levels have on infections as well as efficacy of transfusions.
Ulka Vaishampayan, MD, and Neeraj Agarwal, MD, spoke with Cancer Therapy Advisor about treatment recommendations for patients newly diagnosed with metastatic RCC.
Dual expression of MYC and BCL2 was associated with worse survival among patients with GCB-like DLBCL, though this status was not associated with any outcomes among patients with ABC-like DLBCL.
Researchers found that, among men previously treated for lymphoma, the incidence of breast cancer is higher than in the general population.
Immune checkpoint inhibitors may be effective for treating elderly patients with melanoma without dramatically increasing toxicity.
Long-term follow-up data from randomized trials on Hodgkin lymphoma support current risk-adapted therapeutic approaches for early-stage disease.